PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.\', \'Department of Medical Oncology, Erasmus Medical Centre, Rotterdam, Netherlands; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, Netherlands. Electronic address: a.vanderveldt@erasmusmc.nl.\', \'Department of Viroscience, Erasmus Medical Centre, Rotterdam, Netherlands.\', \'Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.\', \'Department of Respiratory Medicine, Erasmus Medical Centre, Rotterdam, Netherlands.\', \'Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.\', \'Department of Pulmonary Diseases, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.\', \'Comprehensive Cancer Organization the Netherlands, Utrecht, Netherlands.\', \'Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands.\', \'Research Centre for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.\', \'Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands.\', \'Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands.\', \'Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.\', \'Department of Medical Microbiology and Infection Prevention, University Medical Centre Groningen, University of Groningen, Groningen, Netherlands; Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1470-2045(21)00574-X10.1016/S1470-2045(21)00574-X
?:hasPublicationType
?:journal
  • The Lancet. Oncology
is ?:pmid of
?:pmid
?:pmid
  • 34767759
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34767759>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34767759>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all